Site Density Functional Theory and Structural Bioinformatics Analysis of the SARS-CoV Spike Protein and hACE2 Complex.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
26 Jan 2022
Historique:
received: 17 12 2021
revised: 20 01 2022
accepted: 21 01 2022
entrez: 15 2 2022
pubmed: 16 2 2022
medline: 19 2 2022
Statut: epublish

Résumé

The entry of the SARS-CoV-2, a causative agent of COVID-19, into human host cells is mediated by the SARS-CoV-2 spike (S) glycoprotein, which critically depends on the formation of complexes involving the spike protein receptor-binding domain (RBD) and the human cellular membrane receptor angiotensin-converting enzyme 2 (hACE2). Using classical site density functional theory (SDFT) and structural bioinformatics methods, we investigate binding and conformational properties of these complexes and study the overlooked role of water-mediated interactions. Analysis of the three-dimensional reference interaction site model (3DRISM) of SDFT indicates that water mediated interactions in the form of additional water bridges strongly increases the binding between SARS-CoV-2 spike protein and hACE2 compared to SARS-CoV-1-hACE2 complex. By analyzing structures of SARS-CoV-2 and SARS-CoV-1, we find that the homotrimer SARS-CoV-2 S receptor-binding domain (RBD) has expanded in size, indicating large conformational change relative to SARS-CoV-1 S protein. Protomer with the up-conformational form of RBD, which binds with hACE2, exhibits stronger intermolecular interactions at the RBD-ACE2 interface, with differential distributions and the inclusion of specific H-bonds in the CoV-2 complex. Further interface analysis has shown that interfacial water promotes and stabilizes the formation of CoV-2/hACE2 complex. This interaction causes a significant structural rigidification of the spike protein, favoring proteolytic processing of the S protein for the fusion of the viral and cellular membrane. Moreover, conformational dynamics simulations of RBD motions in SARS-CoV-2 and SARS-CoV-1 point to the role in modification of the RBD dynamics and their impact on infectivity.

Identifiants

pubmed: 35164065
pii: molecules27030799
doi: 10.3390/molecules27030799
pmc: PMC8839245
pii:
doi:

Substances chimiques

Spike Glycoprotein, Coronavirus 0
spike protein, SARS-CoV-2 0
ACE2 protein, human EC 3.4.17.23
Angiotensin-Converting Enzyme 2 EC 3.4.17.23

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Institute of Theoretical and Experimental Biophysics
ID : 075-00381-21-00
Organisme : G.A. Krestov Institute of Solution Chemistry, Russian Academy of Sciences
ID : 0077-2019-0033

Références

Nucleic Acids Res. 2014 Jul;42(Web Server issue):W271-6
pubmed: 24771341
J Comput Aided Mol Des. 2020 Dec;34(12):1219-1228
pubmed: 32918236
Biointerphases. 2021 Jan 28;16(1):011006
pubmed: 33706521
Nature. 2020 May;581(7807):221-224
pubmed: 32225175
J Chem Theory Comput. 2010 Mar 9;6(3):607-624
pubmed: 20440377
J Chem Phys. 2011 Dec 21;135(23):234104
pubmed: 22191861
Bioinformatics. 2016 Dec 1;32(23):3676-3678
pubmed: 27503228
J Chem Phys. 2010 Feb 14;132(6):064106
pubmed: 20151732
J Phys Chem B. 2015 Dec 10;119(49):15203-11
pubmed: 26565946
Protein Sci. 2018 Jan;27(1):293-315
pubmed: 29067766
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
J Comput Chem. 2004 Jul 15;25(9):1157-74
pubmed: 15116359
Phys Chem Chem Phys. 2019 Sep 21;21(35):18958-18969
pubmed: 31453590
Phys Chem Chem Phys. 2017 Dec 6;19(47):31965-31981
pubmed: 29177351
Biophys J. 2001 Jan;80(1):505-15
pubmed: 11159421
J Phys Chem B. 2021 Oct 14;125(40):11219-11231
pubmed: 34597044
J Chem Phys. 2021 Aug 14;155(6):064501
pubmed: 34391371
Proteins. 2001 Aug 1;44(2):150-65
pubmed: 11391777
Phys Rev Lett. 2008 Nov 21;101(21):216401
pubmed: 19113431
J Phys Chem B. 2010 Feb 11;114(5):1946-53
pubmed: 20085242
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
Annu Rev Virol. 2016 Sep 29;3(1):237-261
pubmed: 27578435
J Chem Phys. 2020 Jan 31;152(4):041101
pubmed: 32007044
J Chem Phys. 2006 Jul 21;125(3):34509
pubmed: 16863364
J Chem Phys. 2009 Aug 21;131(7):074503
pubmed: 19708747
J Chem Inf Model. 2017 Nov 27;57(11):2646-2656
pubmed: 28991467
Phys Chem Chem Phys. 2017 Aug 9;19(31):20474-20483
pubmed: 28749490
Phys Chem Chem Phys. 2021 Jan 21;23(2):1590-1600
pubmed: 33409510
J Chem Theory Comput. 2008;4(11):1928-1939
pubmed: 19262740
J Phys Chem Lett. 2020 Dec 17;11(24):10482-10488
pubmed: 33274945
J Chem Theory Comput. 2013 Apr 9;9(4):1896-908
pubmed: 26583541
Adv Virol. 2011;2011:734690
pubmed: 22312351
Proteins. 2010 Nov 1;78(14):2908-21
pubmed: 20715289
J Chem Phys. 2012 Oct 21;137(15):154101
pubmed: 23083142
J Chem Inf Model. 2017 Jul 24;57(7):1652-1666
pubmed: 28565907
PLoS One. 2020 Nov 10;15(11):e0241168
pubmed: 33170884
Curr Med Chem. 2013;20(23):2839-60
pubmed: 23651302
Cell. 2020 Oct 29;183(3):730-738.e13
pubmed: 32979942
J Chem Phys. 2017 Sep 7;147(9):094107
pubmed: 28886632
NPJ Vaccines. 2020 Mar 6;5(1):18
pubmed: 32194995
J Chem Phys. 2012 Mar 21;136(11):114106
pubmed: 22443748
Proc Natl Acad Sci U S A. 2020 May 26;117(21):11727-11734
pubmed: 32376634
J Comput Chem. 2012 Jul 5;33(18):1536-43
pubmed: 22522665
Amino Acids. 2015 May;47(5):1015-23
pubmed: 25663287
Soft Matter. 2017 Feb 8;13(6):1120-1131
pubmed: 28093583
J Phys Chem B. 2010 Jul 1;114(25):8505-16
pubmed: 20524650
Chem Rev. 2012 Jan 11;112(1):289-320
pubmed: 22191548
J Comput Chem. 2014 May 15;35(13):1010-23
pubmed: 24659143
J Phys Chem B. 2020 Jul 16;124(28):5907-5912
pubmed: 32551652
Science. 2005 Sep 16;309(5742):1864-8
pubmed: 16166518
Science. 2020 Mar 27;367(6485):1444-1448
pubmed: 32132184
J Phys Chem B. 2017 Jul 20;121(28):6898-6908
pubmed: 28695743
Curr Pharm Des. 2011;17(17):1695-708
pubmed: 21619532
Nat Chem. 2021 Jul;13(7):651-659
pubmed: 34031561
Amino Acids. 2016 Jul;48(7):1685-94
pubmed: 27085633
Nat Commun. 2020 Mar 27;11(1):1620
pubmed: 32221306
Trends Immunol. 2020 Apr;41(4):271-273
pubmed: 32173256
PLoS One. 2015 Mar 13;10(3):e0120416
pubmed: 25767879
J Biomol NMR. 2011 May;50(1):43-57
pubmed: 21448735
J Comput Chem. 2012 Jun 30;33(17):1478-94
pubmed: 22522583
Cell. 2020 Oct 29;183(3):739-751.e8
pubmed: 32991842
Biophys Chem. 2014 Jun;190-191:25-31
pubmed: 24780753
Nature. 2020 May;581(7807):215-220
pubmed: 32225176
Sci Rep. 2018 Oct 24;8(1):15701
pubmed: 30356097

Auteurs

Nitesh Kumawat (N)

School of Mathematics, Statistics and Computational Sciences, Central University of Rajasthan, Ajmer 305817, India.

Andrejs Tucs (A)

Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8568, Japan.

Soumen Bera (S)

Department of Microbiology, University of Tennessee, Knoxville, TN 37996, USA.

Gennady N Chuev (GN)

Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, 142290 Pushchino, Russia.

Marat Valiev (M)

Molecular Sciences Software Group, Environmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, WA 99352, USA.

Marina V Fedotova (MV)

G.A. Krestov Institute of Solution Chemistry, Russian Academy of Sciences, 153045 Ivanovo, Russia.

Sergey E Kruchinin (SE)

G.A. Krestov Institute of Solution Chemistry, Russian Academy of Sciences, 153045 Ivanovo, Russia.

Koji Tsuda (K)

Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8568, Japan.
RIKEN Center for Advanced Intelligence Project, Tokyo 103-0027, Japan.
Research and Services Division of Materials Data and Integrated System, National Institute for Materials Science, Tsukuba 305-0044, Japan.

Adnan Sljoka (A)

RIKEN Center for Advanced Intelligence Project, Tokyo 103-0027, Japan.
Department of Chemistry, York University, Toronto, ON M3J 1P3, Canada.

Amit Chakraborty (A)

Department of Mathematics, School of Physical Sciences, Sikkim University, Gangtok 737102, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH